Indo US Bio-Tech Reports Strong PAT Growth Amid Score Adjustment in August 2025
Indo US Bio-Tech has announced its financial results for the quarter ending June 2025, revealing a Profit After Tax of Rs 8.38 crore, a year-on-year growth of 127.10%. Net sales reached Rs 64.15 crore, reflecting a 58.43% increase, indicating strong operational performance and demand.
Indo US Bio-Tech, operating within the Other Agricultural Products sector, has recently reported its financial results for the quarter ending June 2025. The results, announced on August 12, 2025, indicate notable developments in the company's financial metrics.The Profit After Tax (PAT) for the latest six-month period stands at Rs 8.38 crore, reflecting a significant year-on-year growth of 127.10%. This upward trend in PAT suggests a robust operational performance during this timeframe. Additionally, the company's net sales reached Rs 64.15 crore, marking a year-on-year increase of 58.43%. This positive trajectory in sales indicates strong demand and operational efficiency.
Despite these encouraging financial indicators, the overall evaluation of Indo US Bio-Tech has undergone an adjustment, with the score reflecting a shift from 19 to 16 over the past three months. This revision in its score highlights the dynamic nature of the company's financial landscape.
For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
